Association of breast cancer with quantitative mammographic density measures for women receiving contrast-enhanced mammography

JNCI Cancer Spectr. 2024 Apr 30;8(3):pkae026. doi: 10.1093/jncics/pkae026.

Abstract

Women with high mammographic density have an increased risk of breast cancer. They may be offered contrast-enhanced mammography to improve breast cancer screening performance. Using a cohort of women receiving contrast-enhanced mammography, we evaluated whether conventional and modified mammographic density measures were associated with breast cancer. Sixty-six patients with newly diagnosed unilateral breast cancer were frequency matched on the basis of age to 133 cancer-free control individuals. On low-energy craniocaudal contrast-enhanced mammograms (equivalent to standard mammograms), we measured quantitative mammographic density using CUMULUS software at the conventional intensity threshold ("Cumulus") and higher-than-conventional thresholds ("Altocumulus," "Cirrocumulus"). The measures were standardized to enable estimation of odds ratio per adjusted standard deviation (OPERA). In multivariable logistic regression of case-control status, only the highest-intensity measure (Cirrocumulus) was statistically significantly associated with breast cancer (OPERA = 1.40, 95% confidence interval = 1.04 to 1.89). Conventional Cumulus did not contribute to model fit. For women receiving contrast-enhanced mammography, Cirrocumulus mammographic density may better predict breast cancer than conventional quantitative mammographic density.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Breast / diagnostic imaging
  • Breast / pathology
  • Breast Density
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / pathology
  • Case-Control Studies
  • Contrast Media* / administration & dosage
  • Female
  • Humans
  • Logistic Models
  • Mammography*
  • Middle Aged
  • Odds Ratio

Substances

  • Contrast Media